FAT EMULSION VEHICLE FOR INTRAVENOUS ADMINISTRATION OF AN AQUEOUS INSOLUBLE DRUGFORTNER CL; GROVE WR; BOWIE D et al.1975; AMER. J. HOSP. PHARM.; U.S.A.; DA. 1975; VOL. 32; NO 6; PP. 582-584; BIBL. 5REF.Article

MEPERIDINE FOR THE TREATMENT OF SHAKING CHILLS AND FEVERBURKS LC; AISNER J; FORTNER CL et al.1980; ARCH. INTERN. MED.; USA; DA. 1980; VOL. 140; NO 4; PP. 483-484; BIBL. 7 REF.Article

CYTOSINE ARABINOSIDE FOR LOCALIZED HERPES ZOSTER IN PATIENTS WITH CANCER: FAILURE IN A CONTROLLED TRIAL = L'EPREUVE DE LA CYTOSINE ARABINOSIDE DANS LE TRAITEMENT DE FORMES LOCALISEES DE ZONA CHEZ LES CANCEREUX: INSUCCES D'UN ESSAISCHIMPFF SC; FORTNER CL; GREENE WH et al.1974; J. INFECT. DIS.; U.S.A.; DA. 1974; VOL. 130; NO 6; PP. 673-676; BIBL. 14 REF.Article

A BENZQUINAMIDE-INDUCED EXTRAPYRAMIDAL REACTION.GROVE WR; BENDER JF; FORTNER CL et al.1976; DRUG INTELLIG. CLIN. PHARM.; U.S.A.; DA. 1976; VOL. 10; NO 11; PP. 638-639; BIBL. 6 REF.Article

PIPERACILLIN OR TICARCILLIN PLUS AMIKACIN: A DOUBLE-BLIND PROSPECTIVE COMPARISON OF EMPIRIC ANTIBIOTIC THERAPY FOR FEBRILE GRANULOCYTOPENIC CANCER PATIENTSWADE JC; SCHIMPFF SC; NEWMAN KA et al.1981; AM. J. MED.; ISSN 0002-9343; USA; DA. 1981; VOL. 71; NO 6; PP. 983-990; BIBL. 27 REF.Article

POTENTIAL OF MEZLOCILLIN AS EMPIRIC SINGLE-AGENT THERAPY IN FEBRILE GRANULOCYTOPENIC CANCER PATIENTSWADE JC; SCHIMPFF SC; NEWMAN KA et al.1980; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1980; VOL. 18; NO 2; PP. 299-306; BIBL. 28 REF.Article

INFECTION IN ACUTE LEUKEMIA PATIENTS RECEIVING ORAL NONABSORBABLE ANTIBIOTICS.HAHN DM; SCHIMPFF SC; FORTNER CL et al.1978; ANTIMICROB. AGENTS CHEMOTHERAPY; USA; DA. 1978; VOL. 13; NO 6; PP. 958-964; BIBL. 24 REF.Article

COMPARATIVE AUDITORY TOXICITY OF AMINOGLYCOSIDE ANTIBIOTICS IN LEUKOPENIC PATIENTSBENDER JF; FORTNER CL; SCHIMPFF SC et al.1979; AMER. J. HOSP. PHARM.; USA; DA. 1979; VOL. 36; NO 8; PP. 1083-1087; BIBL. 29 REF.Article

A COMPARATIVE TRIAL OF TOBRAMYCIN VS GENTAMICIN IN COMBINATION WITH VANCOMYCIN AND NYSTATIN FOR ALIMENTARY TRACT SUPPRESSION IN LEUKEMIC PATIENTSBENDER JF; SCHIMPFF SC; YOUNG VM et al.1979; EUROP. J. CANCER; GBR; DA. 1979; VOL. 15; SUPPL. 1; PP. 35-44; BIBL. 23 REF.Conference Paper

COMPARISON OF BASIC INFECTION PREVENTION TECHNIQUES, WITH STANDARD ROOM REVERSE ISOLATION OR WITH REVERSE ISOLATION PLUS ADDED AIR FILTRATIONSCHIMPFF SC; HAHN DM; BROUILLET MD et al.1978; LEUKEMIA RES.; GBR; DA. 1978; VOL. 2; NO 3; PP. 231-240; BIBL. 27 REF.Article

A COMPARISON OF TRIMETHOPRIM-SULFAMETHOXAZOLE PLUS NYSTATIN WITH GENTAMICIN PLUS NYSTATIN IN THE PREVENTION OF INFECTIONS IN ACUTE LEUKEMIAWADE JC; SCHIMPFF SC; HARGADON MT et al.1981; N. ENGL. J. MED.; ISSN 0028-4793; USA; DA. 1981; VOL. 304; NO 18; PP. 1057-1062; BIBL. 27 REF.Article

ROLE OF VANCOMYCIN AS A COMPONENT OF ORAL NONABSORBABLE ANTIBIOTICS FOR MICROBIAL SUPPRESSION IN LEUKEMIC PATIENTSBENDER JF; SCHIMPFF SC; YOUNG VM et al.1979; ANTIMICROB. AGENTS CHEMOTHERAPY; USA; DA. 1979; VOL. 15; NO 3; PP. 455-460; BIBL. 18 REF.Article

COMPARISON OF STANDARD VERSUS PHARMACOKINETICALLY ADJUSTED AMIKACIN DOSING IN GRANULOCYTOPENIC CANCER PATIENTSFINLEY RS; FORTNER CL; DEJONGH CA et al.1982; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1982; VOL. 22; NO 2; PP. 193-197; BIBL. 28 REF.Article